HAVIT Blog
Science-backed guides on habits, sleep, nutrition, and movement.
All articles
Semaglutide Tracker: What to Track (Ozempic, Wegovy, Rybelsus)
A semaglutide tracker logs your dose, injection site or pill timing, weight trend, protein & side effects across Ozempic, Wegovy & Rybelsus. Here's what to track.
Shotsy Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs Shotsy
Looking for a Shotsy alternative on Ozempic or Zepbound? What Shotsy's shot tracker does well, where it stops, and how an all-in-one GLP-1 app compares.
Tirzepatide Side Effects: Mounjaro & Zepbound (2026)
The most common tirzepatide side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent medical care.
Tirzepatide Tracker: What to Track on Mounjaro & Zepbound
A tirzepatide tracker logs your weekly dose, injection site, weight trend, protein & side effects — for Mounjaro or Zepbound. Learn what to track and why.
Wegovy Side Effects: Nausea, Hair Loss & Timeline (2026)
Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Because Wegovy titrates to a higher 2.4 mg dose, these are reported more often than with Ozempic. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying.
Wegovy Tracker: What to Track on Wegovy & How (2026)
A Wegovy tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on semaglutide and why it matters.
WeightWatchers GLP-1 Alternative: An Honest 2026 Comparison — Havit vs WeightWatchers
Looking for a WeightWatchers GLP-1 alternative? What WW's Points program and WeightWatchers Clinic do well, where they leave gaps, and how to choose a tracker.
Zepbound Side Effects: Nausea, Hair Loss & Timeline (2026)
Zepbound's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Injection-site reactions and hair loss are also labeled. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent care.
Zepbound Tracker: What to Track on Zepbound & How (2026)
A Zepbound tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on tirzepatide and why it matters.
GLP-1 Alone Is Not Enough — The "Drug + Behavioral Therapy" Model Recommended by WHO/ADA, and HAVIT's M0/M1/M2 Stages
GLP-1 receptor agonists (Wegovy, Mounjaro, Zepbound) produce 15–22% average weight loss (STEP 1, SURMOUNT-1). But STEP 4 reported +11.6%p regain one year after discontinuation — about 78% of weight loss returned. WHO (2022) and ADA Standards (2024) explicitly recommend behavioral therapy alongside pharmacotherapy, and STEP 3 (JAMA 2021) showed Intensive Behavioral Therapy in combination achieved nearly 3× the weight loss of standard-care combination (−16% vs −5.7%). HAVIT structures this in 3 stages — pre-medication (M0), adaptation (M1), maintenance/discontinuation (M2) — integrating drugs, muscle preservation, and behavior learning. HAVIT does not prescribe GLP-1; prescription, dosing, and discontinuation remain the physician's domain.
Democratizing Body Composition Checks — How HAVIT's Survey-Based Model Achieves Clinical-Tool-Grade Accuracy (n=70 Internal Comparison Study Using InBody as Reference)
Effective obesity and metabolic-health management starts from an accurate body composition baseline. Standard tools (DEXA, InBody) carry a three-way barrier — costly, in-person, expensive per use. HAVIT estimates body fat %, muscle mass, visceral fat, BMR, TDEE, WHtR, and biological age from smartphone survey + basic body info (height, weight, sex, age) alone. n=70 internal comparison vs InBody: ±5% agreement 92.9%, MAE 2.42%p, CCC 0.93, statistically significant over the Deurenberg standard formula across 6 indicators (Steiger Z p=0.030). The goal is democratizing body composition checks for non-clinical daily tracking — anyone, anywhere, anytime, without additional equipment. HAVIT is not a medical diagnostic tool.
The New Standard for Digital Health Coaching — How HAVIT's 8-Step AI Coaching Engine Integrates Personalization, Immediate Feedback, and Behavior Triggers
Most health apps deliver static prescriptions like 'eat 1,500 kcal today.' But the literature shows digital behavioral intervention effectiveness scales with personalization · feedback immediacy · behavior triggers (Tate 2003 JAMA; Patel 2015 Ann Intern Med). HAVIT's 8-step coaching engine is built on the Fogg Behavior Model (B = M × A × P) and Self-Determination Theory (autonomy · competence · relatedness), matching prescriptions from 126 archetypes × 2,000+ behavior library to changing user signals each moment. HAVIT is not a medical diagnostic tool; clinical diagnosis and treatment decisions are the physician's domain.
